A neonatal screening in Lebanon: Results of five years' experience

Annals of Saudi Medicine

Volumn 23, Issue 1-2, 2003, Pages 16-19

  Daher, Rose ^a   Beaini, Mona ^a   Mahfouz, Rami ^a   Cortas, Najwa ^a   Younis, Khalid A ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Congenital hypothyroidism; Glucose 6 phosphate dehydrogenase deficiency; Neonatal screening; Phenylketonuria

Indexed keywords

GLUCOSE 6 PHOSPHATE DEHYDROGENASE; LEVOTHYROXINE SODIUM; PHENYLALANINE; THYROTROPIN;

AGE DISTRIBUTION; AMINO ACID BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; CONGENITAL HYPOTHYROIDISM; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; HYPERPHENYLALANINEMIA; INCIDENCE; LEBANON; MAJOR CLINICAL STUDY; MALE; NEWBORN; NEWBORN DISEASE; NEWBORN JAUNDICE; NEWBORN SCREENING; PHENYLKETONURIA; PRIORITY JOURNAL; THYROTROPIN BLOOD LEVEL;

EID: 0038174983     PISSN: 02564947     EISSN: None     Source Type: Journal    
DOI: 10.5144/0256-4947.2003.16     Document Type: Article

References (32)

1. Guthrie R. The origin of newborn screening. Screening 1992;1:5-15.
2. Barnes ND. Screening for congenital hypothyroidism: the first decade. Arch Dis Child 1985;60:587-92.
3. Bartsocas C. Red cell enzymopathies and screening. In: Benson PE, editor. Screening and management of potentially treatable genetic metabolic disorders. London: MTP Press, 1983:191-205.
4. Derkaloustian M, Naffah J, Loiselet J. Genetic diseases in Lebanon. Am J Med Genet 1980;7:187-203.
5. Mabry CC. Phenylketonuria: contemporary screening and diagnosis. Ann Clin Lab Sci 1990;20:393-7.
6. Frezal J, Farriaux JP. Phenylketonuria yesterday and today. Evaluation of the work of systematic neonatal screening. Rev Pract 1992;42:2316-26.
7. Klett M. Epidemiology of congenital hypothyroidism. Exp Clin Endocrinol 1997;105(Suppl 4):19-23.
8. Committee on Genetics. American Academy of Pediatrics. Newborn screening fact sheets. Pediatrics 1989;83:449-64.
9. Willi SM, Moshang T Jr. Diagnostics dilemmas: results of screening tests for congenital hypothyroidism. Pediatr Clin North Am 1991; 38:555-66.
10. Grant DB. Congenital hypothyroidism: optimal management in the light of 15 years experience of screening. Arch Dis Child 1995;72: 85-9.
11. Teebi AS, Farag TI, editors. Genetic disorders among Arab populations. New York: Oxford monographs on medical genetics No. 30. London: Oxford University Press, 1997:275.
12. Kaplan M, Hammerman C, Rudensky B, Kvit R, Abramav A. Enzymatic activity in glucose-6-phosphate dehydrogenase - normal and deficient - neonates measured with a commercial kit. Clin Chem 1995;41:1665-7.
13. Ransinghe WAEP, Sitchon EC, Malik AS. Glucose-6-phosphate dehydrogenase deficiency in newborn infants of Eastern Saudi Arabia. Ann Saudi Med 1988;8:356-8.
14. Dussault JH. Screening for congenital hypothyroidism. Clin Obstet Gynecol 1997;40:117-23.
15. Gruters A, Delange F, Giovannelli G, et al. Guidelines for neonatal screening programmes for congenital hypothyroidism. Eur J Pediatr 1993;152:974-5.
16. American Academy of Pediatrics, Section on Endocrinology and Committee on Genetics, and American Thyroid Association Committee on Public Health. Newborn screening for congenital hypothyroidism: recommended guidelines. Pediatrics 1993;91:1203-9.
17. Holtzman C, Slazyk WE, Cordero JF, Hannon WH. Descriptive epidemiology of missed cases of phenylketonuria and congenital hypothyroidism. Pediatrics 1986;78:553-8.
18. Sinai LN, Kim SC, Casey R, Pinto MSA. Phenylketonuria screening: effect of early newborn discharge. Pediatrics 1995;96:605-8.
19. Delange F, Dache A, Bourdoux P, et al. Increased risk of primary hypothyroidism in preterm infants. J Pediatr 1984;105:459-62.
20. Al Jurayyan N, Al Nuaim AA, Redha MA, et al. Neonatal screening for congenital hypothyroidism in Riyadh: analysis of six years' experience. Ann Saudi Med 1996;16:20-3.
21. Siebner R, Merlob P, Kaiserman I, Sack J. Congenital anomalies concomitant with persistant primary congenital hypothyroidism. Am J Med Genet 1992;44:57-60.
22. Macaron C. Congenital hypothyroidism in Lebanon. Leb Med J 1980;31:381-3.
23. Yordam N, Calikoglu AS, Hatun S, et al. Screening for congenital hypothyroidism in Turkey. Eur J Pediatr 1995;154:614-6.
24. Reuss ML, Leviton A, Paneth N, Susser M. Thyroxine values from newborn screening of 919 infants born before 29 weeks' gestation. Am J Public Health 1997;87:1693-7.
25. Fisher DA. Hypothyroxinemia in premature infants: is thyroxine treatment necessary. Thyroid 1999;9:715-20.
26. Rooman RP, Du Caju MV, Op de Beeck LO, Doex M, Van Reempts P, Van Acker KJ. Low thyroxinaemia occurs in the majority of very preterm newborns. Eur J Pediatr 1996;155:211-5.
27. Allen DB, Sieger JE, Litsheim T, Duck SC. Age-adjusted thyrotropin criteria for neonatal screening for hypothyroidism. J Pediatr 1990; 117:309-12.
28. Hunter MK, Mandel SH, Sesser DE, et al. Follow-up of newborns with low thyroxine and nonelevated thyroid-stimulating hormone screening concentrations: results of the 20-year experience in the Northwest Regional Newborn Screening Program. J Pediatr 1998; 132:70-4.
29. Missiou-Tsagaraki S. Screening for glucose-6-phosphate dehydrogenase deficiency as a preventive measure: prevalence among 1,286,000 Greek newborn infants. J Pediatr 1991;119:293-9.
30. Usanga EA, Ameen R. Glucose-6-phosphate dehydrogenase in Kuwait, Syria, Egypt, Iran, Jordan and Lebanon. Hum Hered 2000; 50:158-61.
31. Kurdi-Haidar B, Mason PJ, Berrebi A, et al. Origin and spread of the glucose-6-phosphate dehydrogenase variant (G6PD-Mediterranean) in the Middle East. Am J Hum Genet 1990;47:1013-9.
32. Seashore MR. Neonatal screening for inborn errors of metabolism: update. Semin Perinatol 1990;14:431-8.